Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Predisposition to Burkitt Lymphoma in Williams-Beuren Syndrome

David Guenat, MD, Carmelo Rizzari, Catarina Lundin, MDPhD, Christophe Borg, MD PhD, Jean Soulier, MD PhD, Pierre-Simon Rohrlich, MDPhD

Blood (2014) 124 (21): 2182.

https://doi.org/10.1182/blood.V124.21.2182.2182

Published: 2014

Journal Articles

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

David Guenat, Carmelo Rizzari, MD, PhD, Patrick Edery, MD, PhD, Jean Soulier, MD, PhD, Christophe Ferrand, PhD, Christophe Borg, MD, PhD, Pierre-Simon Rohrlich, MD, PhD

Blood (2013) 122 (21): 4898.

https://doi.org/10.1182/blood.V122.21.4898.4898

Published: 2013

Journal Articles

Tyrosine Kinase Inhibitors Dasatinib, Nilotinib and Imatinib Have an Impact on Both CD8+ T Lymphocytes and CD4+CD25+FoxP3+ Regulatory T Cells by Downregulation of the NF-κB Pathway.

Fei Fei, MD, Yingzhe Yu, Anita Schmitt, MD, Jinfei Chen, PhD, MD, Baoan Chen, PhD, MD, Markus Rojewski, MD, Mark Ringhoffer, MD, Stefanie von Harsdorf, MD, Jochen Greiner, PhD, MD, Marlies Goetz, Philippe Guillaume, PhD, Hartmut Dohner, PhD, MD, Donald Bunjes, PhD, MD, Michael Schmitt, PhD, MD

Blood (2007) 110 (11): 2368.

https://doi.org/10.1182/blood.V110.11.2368.2368

Published: 2007

Journal Articles

Gene Expression Profiling of Myeloma Cells at Diagnosis Can Predict Response to Therapy with Thalidomide and Dexamethasone Combination.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica Haug, MD, Michael Kline, PhD, Wee Joo Chng, Emily Blood, MS, Leif Bergsagel, MD, John A. Lust, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 508.

https://doi.org/10.1182/blood.V106.11.508.508

Published: 2005

Journal Articles

Frizzled 9 knock-out mice have abnormal B-cell development

Erik A. Ranheim, Helen C. K. Kwan, Tannishtha Reya, Yu-Ker Wang, Irving L. Weissman, Uta Francke

Blood (2005) 105 (6): 2487–2494.

https://doi.org/10.1182/blood-2004-06-2334

Published: 2005

Journal Articles

Williams-Beuren Syndrome Critical Region-5/Non-T Cell Activation Linker: A Novel Target Gene of AML1/ETO.

Michael Lübbert, MD PhD, Michael Stock, PhD, Tobias Berg, Manfred Fliegauf, PhD

Blood (2004) 104 (11): 2898.

https://doi.org/10.1182/blood.V104.11.2898.2898

Published: 2004

NARROW

Predisposition to Burkitt Lymphoma in Williams-Beuren Syndrome

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

Tyrosine Kinase Inhibitors Dasatinib, Nilotinib and Imatinib Have an Impact on Both CD8+ T Lymphocytes and CD4+CD25+FoxP3+ Regulatory T Cells by Downregulation of the NF-κB Pathway.

Gene Expression Profiling of Myeloma Cells at Diagnosis Can Predict Response to Therapy with Thalidomide and Dexamethasone Combination.

Frizzled 9 knock-out mice have abnormal B-cell development

Williams-Beuren Syndrome Critical Region-5/Non-T Cell Activation Linker: A Novel Target Gene of AML1/ETO.

Email alerts

ASH Publications

American Society of Hematology

Predisposition to Burkitt Lymphoma in Williams-Beuren Syndrome

Genetic Characterization Of Williams Beuren Syndrome Associated With Non-Hodgkin Lymphoma

Tyrosine Kinase Inhibitors Dasatinib, Nilotinib and Imatinib Have an Impact on Both CD8+ T Lymphocytes and CD4+CD25+FoxP3+ Regulatory T Cells by Downregulation of the NF-κB Pathway.

Gene Expression Profiling of Myeloma Cells at Diagnosis Can Predict Response to Therapy with Thalidomide and Dexamethasone Combination.

Frizzled 9 knock-out mice have abnormal B-cell development

Williams-Beuren Syndrome Critical Region-5/Non-T Cell Activation Linker: A Novel Target Gene of AML1/ETO.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only